BIAF Announces Mexican Patent Allowance for CyPath Lung, Expanding Global IP Portfolio, 92% Sensitivity, 87% Specificity
bioAffinity Technologies, Inc. Common Stock · SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH · Now $1.75
-8.2% in 1h after detection
Post-detection moves
1h
-8.2%
1d
-7.3%
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS